Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Aug;187(2):138-139.
doi: 10.1111/bjd.21591. Epub 2022 May 9.

Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum

Christina H Scheel  1 , Nessr Abu Rached  1 , Thilo Gambichler  1
Affiliations
Comment

Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum

Christina H Scheel et al. Br J Dermatol. 2022 Aug.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Scala E, Cacciapuoti S, Garzorz-Stark N et al. Hidradenitis suppurativa: where we are and where we are going. Cells 2021; 10:2094.
    1. Hessam S, Scholl L, Sand M et al. Distinguishing mild, moderate, and severe hidradenitis suppurativa. JAMA Dermatol 2018; 154:972.
    1. Frew JW. Hidradenitis suppurativa is an autoinflammatory keratinization disease: a review of the clinical, histologic, and molecular evidence. JAAD Int 2020; 1:62-72.
    1. Kimball AB, Okun MM, Williams DA et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med 2016; 375:422-34.
    1. Glatt S, Jemec GBE, Forman S et al. Efficacy and safety of bimekizumab in moderate to severe hidradenitis suppurativa. JAMA Dermatol 2021; 157:1279-88.